Skip to content

Checking the risk of muscle loss in women after menopause and comparing task based training and regular exercise to see which works better

Screening Postmenopausal Women For Sarcopenia Risk:A Randomised Controlled Trial Comparing Functional Task Oriented Training Versus Conventional Treatment On Muscle Strength,Fatigue,Functional Outcomes And Biomarkers - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107925
Enrollment
100
Registered
2026-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Functional task oriented training: Group A structured home-based exercises 6 days per week for 3 months including resistance, balance, endurance & circuit training With no specialized

Sponsors

Bharati vidyapeeth school of physiotherapy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women aged 50 65 years who have experienced amenorrhea for at least 12 months, confirmed by blood tests showing low estrogen levels. 2. Pre-sarcopenia or risk of sarcopenia based on AWGS 2019 criteria (low muscle mass or strength without severe mobility loss) having a score of SARC-CalF more than or equal to 11. 3. Ambulatory, able to walk independently without assistive devices 4. Stable medical condition and not on anti-inflammatory or hormonal therapy in the past 6 months 5. Willing to provide informed consent and comply with intervention and follow-ups

Exclusion criteria

Exclusion criteria: 1- severe cardiopulmonary, renal, hepatic or neurological disorders affecting exercise participation 2- recent fractures or orthopedic surgery or severe arthritis limiting mobility 3- current hormone replacement therapy or long term corticosteroid use 4- active malignancy, autoimmune, or chronic inflammatory disease. 5-uncontrolled diabetes or hypertension. 6- participation in regular resistance training. 7- cognitive impairement or psychiatric illness limiting compliance

Design outcomes

Primary

MeasureTime frame
Biomarkers- IL6 & CRP Muscle Strength- Handheld dynamometer Fatigue- Fatigue severity scale Functional outcomes- ICF Timepoint: Pre- baseline, Interim- 3 weeks and Post intervention at 3 months

Secondary

MeasureTime frame
Peak expiratory flow rateTimepoint: Pre- baseline, Interim- 3 weeks & Post intervention at 3 months

Countries

India

Contacts

Public ContactDr Jinal Naik

Bharati vidyapeeth school of physiotherapy

sneha.katke@bharatividyapeeth.edu9158587070

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026